← Back to patent-cliff list
利多卡因/丙胺卡因皮肤气雾剂
Tier C — Watch / tradeLidocaine/Prilocaine cutaneous spray
Recordati Ireland Ltd
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：SCNA、VDCCs
Brand：Senstend、Fortacin
Indications (approved)：早泄、生理性性功能障碍
Regional status
US
临床三期
2007-10-01
EU
批准上市
2013-11-15
China
批准上市
2026-06-10
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Lidocaine/Prilocaine cutaneous spray?
Approved indications include: 早泄, 生理性性功能障碍.
When does the Lidocaine/Prilocaine cutaneous spray patent expire?
No public expiry year is available for Lidocaine/Prilocaine cutaneous spray yet; this page updates once verified.
How do I get a quote for Lidocaine/Prilocaine cutaneous spray intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24